CV Sciences, Inc.
corporate_fare Company Profile
CV Sciences, Inc. (OTC:CVSI) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 13 items for CVSI at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-26, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for CVSI spans 8-K, 4, 10-Q, DEF 14A.
Recent high-impact activity:
- CV Sciences Settles Former Counsel Arbitration, Receives $500,000 Cash
- 10% Owner Charles Cheever Buys $114.8K of CVSI Stock at $0.02
- CV Sciences Q2 Revenue Drops 17.5%, Going Concern Warning Reiterated
- Shareholders Reject Reverse Stock Split Proposal Amidst Going Concern Warning
- Q1 Revenue Drops 11.4%, Net Loss Widens Amid Going Concern & Major Dilution
Financial Snapshot
Short Interest & Short Volume
1.00 days to coverFINRA reported short interest of 36,668 shares in CVSI as of the October 15, 2026 settlement, a 158.4% increase from the prior period — about 1.0 days to cover at its recent average daily volume. On October 29, 2026, 70.3% of CVSI volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.